Titan Pharmaceuticals
TTNP
#11004
Rank
โ‚ฌ5.59 M
Marketcap
4,20ย โ‚ฌ
Share price
-3.76%
Change (1 day)
22.23%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -4,00ย โ‚ฌ

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -4,00ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -6,76ย โ‚ฌ an increase over its 2022 EPS that were of -13,85ย โ‚ฌ.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-4,00ย โ‚ฌ
2023-6,76ย โ‚ฌ-51.22%
2022-13,85ย โ‚ฌ-15.61%
2021-16,42ย โ‚ฌ-81.37%
2020-88,11ย โ‚ฌ-77.52%
2019-392,02ย โ‚ฌ-56.32%
2018-897,52ย โ‚ฌ-59.51%
2017-2.217ย โ‚ฌ-371.81%
2016815,59ย โ‚ฌ-144.35%
2015-1.839ย โ‚ฌ300%
2014-459,70ย โ‚ฌ-121.54%
20132.134ย โ‚ฌ-151.38%
2012-4.154ย โ‚ฌ-11.54%
2011-4.696ย โ‚ฌ188.89%
2010-1.625ย โ‚ฌ-10%
2009-1.806ย โ‚ฌ
2007-7.404ย โ‚ฌ-2.38%
2006-7.585ย โ‚ฌ-39.13%
2005-12.461ย โ‚ฌ-16.87%
2004-14.990ย โ‚ฌ-22.43%
2003-19.324ย โ‚ฌ4.9%
2002-18.421ย โ‚ฌ61.9%
2001-11.378ย โ‚ฌ-13.7%
2000-13.184ย โ‚ฌ78.6%
1999-7.382ย โ‚ฌ-35.87%
1998-11.511ย โ‚ฌ-1824.71%
1997667,42ย โ‚ฌ-102.4%
1996-27.865ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-252.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,79ย โ‚ฌ-219.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-4,21ย โ‚ฌ 5.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-0,18ย โ‚ฌ-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-0,21ย โ‚ฌ-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,97ย โ‚ฌ-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA